<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Multiple Sclerosis</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Multiple Sclerosis</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                20 Questions | 20 Total Marks | 30 min Duration | ~90.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 20 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 30 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 20</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Multiple Sclerosis - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 20</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 20 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following is incorrect about Multiple sclerosis (MS)?", "options": [{"label": "A", "text": "Autoimmune disease", "correct": false}, {"label": "B", "text": "Acute inflammation", "correct": true}, {"label": "C", "text": "Demyelination and gliosis", "correct": false}, {"label": "D", "text": "Neuronal loss", "correct": false}], "correct_answer": "B. Acute inflammation", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Acute inflammation Multiple sclerosis shows CHRONIC inflammation.</p>\n<p><strong>Highyeild:</strong></p><p>Pathophysiology of Multiple sclerosis- Inflammation Macrophage, microglia or B cell ‚Üí react to myelin present it on surface ‚Üí peripheral T cell activated ‚Üí express adhesion molecule ‚Üí cross BBB ‚Üí spread inflammatory cytokines(IFN-Œ≥ , TNF-Œ±) CNS bystanders activated(Epitope spreading) CNS cells activated included Monocytes Microglia dendritic cells NK cells T and B cell Microglia can release damaging NO, free radicals and protease. Dysfunctional regulatory T- cell pathways are also likely to contribute. Triad of Multiple sclerosis - IDG(Inflammation, demyelination, gliosis)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Multiple sclerosis is an autoimmune disease of the central nervous system (CNS). Option: C, D. Multiple sclerosis is characterized by chronic inflammation, demyelination, gliosis (plaques or scarring), and neuronal loss ; the course can be relapsing or progressive</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following are true about Lhermitte‚Äôs symptoms of multiple sclerosis EXCEPT?", "options": [{"label": "A", "text": "An electric shock‚Äìlike sensation", "correct": false}, {"label": "B", "text": "Induced by flexion or other movements of the neck", "correct": false}, {"label": "C", "text": "It is generally self-limited", "correct": false}, {"label": "D", "text": "Commonly radiates into the arms", "correct": true}], "correct_answer": "D. Commonly radiates into the arms", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Commonly radiates into the arms Shock like sensation radiates down the back into the legs. Rarely, it radiates into the arms.</p>\n<p><strong>Highyeild:</strong></p><p>Multiple sclerosis- Lhermitte‚Äôs symptom - An electric shock‚Äìlike sensation typically induced by flexion or other movements of the neck Shock like sensation radiates down the back into the legs . Rarely, it radiates into the arms. It is generally self-limited but may persist for years . Lhermitte‚Äôs symptoms can also occur with other disorders of the cervical spinal cord. e.g. Cervical spondylosis . Options A,B,C are incorrect.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which clinical course of Multiple sclerosis is shown in the diagram below?", "options": [{"label": "A", "text": "Relapsing MS (RMS)", "correct": false}, {"label": "B", "text": "Secondary progressive MS (SPMS)", "correct": true}, {"label": "C", "text": "Primary progressive MS (PPMS)", "correct": false}, {"label": "D", "text": "Clinically isolated syndrome (CIS)", "correct": false}], "correct_answer": "B. Secondary progressive MS (SPMS)", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855026181-QTDM120004IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Secondary progressive MS (SPMS) As the disease began as RMS . However, the clinical course changed later so that the patient experiences deterioration in function unassociated with acute attacks.</p>\n<p><strong>Highyeild:</strong></p><p>DISEASE COURSE OF MULTIPLE SCLEROSIS- Three clinical types of MS exist: Relapsing or bout onset Multiple sclerosis (RMS) 90% of MS cases(Most common ) characterized by discrete attacks of neurologic dysfunction generally evolve over days to weeks (rarely over hours). With initial attacks, there is often substantial or complete recovery over the ensuing weeks to months. However, as attacks continue , recovery may be less evident. Between attacks, patients were traditionally thought to be neurologically stable; However it is now clear that many patients with RMS experience subtle ‚Äúsilent‚Äù progression even when relapse-free. Secondary progressive Multiple sclerosis (SPMS) always begins as RMS. At some point, however, the clinical course changes so that the patient experiences progressive deterioration in function unassociated with acute attacks. SPMS produces a greater amount of fixed neurologic disability than RMS. For a patient with RMS, the risk of developing SPMS was approximately 3% each year in the pretreatment era, meaning that the great majority of RMS would ultimately evolve into SPMS. However, recent case series have indicated a much lower rate of evolution to SPMS, estimated at slightly >1% each year , likely due to the widespread use of effective therapies for MS. Primary progressive Multiple sclerosis (PPMS) 10% of MS cases. These patients do not experience attacks but rather a steady decline in function from disease onset. Compared to RMS, the sex distribution is more even , the disease begins later in life (mean age ~40 years) , and disability develops faster (relative to the onset of the first clinical symptom). Despite these differences, PPMS appears to represent the same underlying illness as RMS. PPMS has the worst prognosis. Progressive MS and Disease Activity Patients with SPMS or even PPMS will occasionally experience relapses, Though, less often than in RMS. Progressive MS patients experiencing relapses or who are found to have acute new lesions on MRI are considered to have ‚Äúactive‚Äù progressive MS.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Relapsing MS (RMS) Will have discrete attacks of neurological dysfunction. Option: C. Primary progressive MS (PPMS) Will not have attacks but rather a steady decline in function from disease onset. Option: D. Clinically isolated syndrome (CIS) Is a single episode while MS is multiple episodes/flareups.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following family history shows the highest risk of Multiple sclerosis?", "options": [{"label": "A", "text": "A fraternal twin has MS", "correct": true}, {"label": "B", "text": "A first cousin has MS", "correct": false}, {"label": "C", "text": "A spouse has MS", "correct": false}, {"label": "D", "text": "sibling has MS", "correct": false}], "correct_answer": "A. A fraternal twin has MS", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>A fraternal twin has MS Among the given options, individuals with a family history of A fraternal twin having MS has a maximum risk of developing Multiple Sclerosis.</p>\n<p><strong>Highyeild:</strong></p><p>Risk of developing Multiple Sclerosis (MS) 1 in 3 If an identical twin has MS 1 in 15 If a fraternal twin has MS 1 in 25 If a sibling has MS 1 in 50 If a parent or half-sibling has MS 1 in 100 If a first cousin has MS 1 in 1000 If a spouse has MS 1 in 1000 If no one in the family has MS</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B, C, D have lesser risk as compared to Option A.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A recently recognized feature of Multiple Sclerosis pathology is shown in Image below. Which is true about it:", "options": [{"label": "A", "text": "Perivascular cuffing of blood vessel by lymphocytes", "correct": true}, {"label": "B", "text": "Perivascular cuffing of blood vessel by neutrophils", "correct": false}, {"label": "C", "text": "Presence of ectopic clusters of lymphocytes in brain parenchyma", "correct": false}, {"label": "D", "text": "Presence of ectopic clusters of neutrophils in brain parenchyma", "correct": false}], "correct_answer": "A. Perivascular cuffing of blood vessel by lymphocytes", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855026262-QTDM120007IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Perivascular cuffing of blood vessel by lymphocytes Photomicrograph is from demyelinating plaque, showing perivascular cuffing of blood vessels by lymphocytes</p>\n<p><strong>Highyeild:</strong></p><p>Demyelination in New MS lesions Begin with perivenular cuffing by inflammatory mononuclear cells , predominantly T cells and macrophages, which also infiltrate the surrounding white matter. At sites of inflammation, the blood-brain barrier (BBB) is disrupted , but unlike in vasculitis, the vessel wall is preserved At the leading edge of lesions, large numbers of cytotoxic CD8 cells are found. Involvement of the humoral immune system is also evident; small numbers of B lymphocytes infiltrate the nervous system, myelin-specific autoantibodies are present on degenerating myelin sheaths , and complement is activated.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Lymphocytes predominate. Option: C. Center is a blood vessel in figure. Option: D. Lymphocytes predominate.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "While diagnosing a patient for Multiple sclerosis, all of the following are MS-typical regions of the CNS except?", "options": [{"label": "A", "text": "Periventricular", "correct": false}, {"label": "B", "text": "Juxtacortical", "correct": false}, {"label": "C", "text": "Supratentorial", "correct": true}, {"label": "D", "text": "Spinal cord", "correct": false}], "correct_answer": "C. Supratentorial", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Supratentorial Evidence for dissemination of Multiple sclerosis in space in the brain Presents as T2+(high intensity) lesions in the MS-characteristic regions- Periventricular Juxtacortical Infratentorial regions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options :- Option A, B, D areMS-typical regions of the CNS.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following are key changes made to the McDonald Criteria in 2017 EXCEPT?", "options": [{"label": "A", "text": "Brain stem and cord lesions can now be counted among the 2 lesions disseminated in space and time", "correct": false}, {"label": "B", "text": "CSF oligoclonal bands can now be used to substitute for demonstration of dissemination in time in some settings", "correct": false}, {"label": "C", "text": "Cortical lesions have been added to juxtacortical lesions as determinant for dissemination in space", "correct": false}, {"label": "D", "text": "Both asymptomatic and now symptomatic MRI lesions can be considered in determining dissemination in space (optic nerve lesions are also included)", "correct": true}], "correct_answer": "D. Both asymptomatic and now symptomatic MRI lesions can be considered in determining dissemination in space (optic nerve lesions are also included)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Both asymptomatic and now symptomatic MRI lesions can be considered in determining dissemination in space (optic nerve lesions are also included) Optic nerve lesions are still excluded from Mcdonald criteria.</p>\n<p><strong>Highyeild:</strong></p><p>2017 revised Mcdonald criteria for Multiple sclerosis- Clinical presentations Additional data needed ‚â• 2 ‚â•2 None ‚â• 2 1 Demonstrate dissemination in space ‚óè       MRI ‚óè       Further clinical attack in a different site 1 ‚â•2 Demonstrate dissemination in time ‚óè       MRI ‚óè       Second clinical attack ‚óè       Positive CSF 1 1 Demonstrate dissemination in Space and time Insidious neurological progression suggestive of Primary Progressive MS One year of disease progression AND 2 of the following a)‚â•1 T2 lesion in the MS characteristic regions b)‚â•2 T2 lesions in the cord c)positive CSF</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A, B, C. Key changes made to the McDonald Criteria in 2017 include the following: Brain stem and cord lesions can now be counted among the 2 lesions disseminated in space and time . CSF oligoclonal bands can now be used to substitute for demonstration of dissemination in time in some settings. Both asymptomatic and now symptomatic MRI lesions can be considered in determining dissemination in space ( optic nerve lesions are still excluded ). Cortical lesions have been added to juxtacortical lesions as determinants for dissemination in space.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30 year old female suffering from MS has become pregnant .Which of the following is TRUE about the effect of pregnancy on Multiple Sclerosis?", "options": [{"label": "A", "text": "Patients experience fewer attacks during gestation in the last trimester and in the first 3 months postpartum", "correct": false}, {"label": "B", "text": "Patients experience increased attacks during gestation in the last trimester and in the first 3 months postpartum", "correct": false}, {"label": "C", "text": "Patients experience fewer attacks in the last trimester, but more attacks in the first 3 months postpartum", "correct": true}, {"label": "D", "text": "Patients experience more attacks in the last trimester, but fewer attacks in the first 3 months postpartum", "correct": false}], "correct_answer": "C. Patients experience fewer attacks in the last trimester, but more attacks in the first 3 months postpartum", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Patients experience fewer attacks in the last trimester, but more attacks in the first 3 months postpartum</p>\n<p><strong>Highyeild:</strong></p><p>Pregnant MS patients experience fewer attacks than expected during gestation (especially in the last trimester) but more attacks than expected in the first 3 months postpartum. When considering the pregnancy year as a whole (i.e., 9 months of pregnancy plus 3 months postpartum), the overall disease course is unaffected. Decisions about childbearing should thus be made based on the mother‚Äôs physical state her ability to care for the child the availability of social support. Disease-modifying therapy is generally discontinued during pregnancy, although the actual risk from the interferons and glatiramer acetate appears to be low.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options :- Option A,B,D are incorrect.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is FALSE about Acute MS (Marburg‚Äôs variant)?", "options": [{"label": "A", "text": "A fulminant demyelinating process", "correct": false}, {"label": "B", "text": "Typically, there are no remissions", "correct": false}, {"label": "C", "text": "When acute MS presents as a solitary, usually cavitary, lesion, a brain tumor is often suspected", "correct": false}, {"label": "D", "text": "Marburg‚Äôs variant seems to follow infection or vaccination", "correct": true}], "correct_answer": "D. Marburg‚Äôs variant seems to follow infection or vaccination", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Marburg‚Äôs variant seems to follow infection or vaccination</p>\n<p><strong>Highyeild:</strong></p><p>Acute MS (Marburg‚Äôs variant) a fulminant demyelinating process that in some cases progresses to death within 1‚Äì2 years . Typically, there are no remissions. Marburg‚Äôs variant does not seem to follow infection or vaccination , And it is unclear whether this syndrome Represents an extreme form of MS Another disease . When an acute demyelinating syndrome presents as a solitary expansile lesion, a brain tumor is often suspected . Such cases are designated tumefactive MS , and a brain biopsy may be required to establish the diagnosis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A,B,C are true about Acute MS (Marburg‚Äôs variant).</p>\n<p><strong>Extraedge:</strong></p><p>Drugs used in Multiple sclerosis Adverse effects Natalizumab PML( Progressive multifocal leukoencephalopathy) Ocrelizumab Infusion-related reactions Fingolimod First dose- First- and second-degree heart block and bradycardia Elevated liver function tests Lymphopenia Glatiramer acetate flushing, chest tightness, dyspnea, palpitations and anxiety after injection Mitoxantrone pregnancy category X</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Based on the following radiological Image, all of the following are true except -", "options": [{"label": "A", "text": "Electronystagmogram is required for diagnosis", "correct": true}, {"label": "B", "text": "Overall disease course is unaffected in pregnancy", "correct": false}, {"label": "C", "text": "MRI has revolutionized the diagnosis", "correct": false}, {"label": "D", "text": "This is an autoimmune disease", "correct": false}], "correct_answer": "A. Electronystagmogram is required for diagnosis", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855026272-QTDM120013IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Electronystagmogram is required for diagnosis Axial first-echo image from t2-weighted sequence shows multiple bright signal abnormalities in white matter , typical for MS(Multiple Sclerosis). In the FLAIR, high intensity lesions suggest demyelination. MRI findings in multiple sclerosis (MS) . Axial first-echo image from T2-weighted sequence demonstrates multiple bright signal abnormalities in white matter, typical for MS. FLAIR image in which the high signal of cerebrospinal fluid (CSF) has been suppressed. CSF appears dark, whereas areas of brain edema or demyelination appear high in signal , as shown here in the corpus callosum (arrows). Lesions in the anterior corpus callosum are frequent in MS and rare in vascular disease .</p>\n<p><strong>Highyeild:</strong></p><p>2017 revised Mcdonald criteria for Multiple sclerosis- Clinical presentations Additional data needed ‚â• 2 ‚â•2 None ‚â• 2 1 Demonstrate dissemination in space ‚óè       MRI ‚óè       Further clinical attack in a different site 1 ‚â•2 Demonstrate dissemination in time ‚óè       MRI ‚óè       Second clinical attack ‚óè       Positive CSF 1 1 Demonstrate dissemination in Space and time Insidious neurological progression suggestive of Primary Progressive MS One year of disease progression AND 2 of the following a)‚â•1 T2 lesion in the MS characteristic regions b)‚â•2 T2 lesions in the cord c)positive CSF Key changes made to the McDonald Criteria in 2017 include the following: Brain stem and cord lesions can now be counted among the 2 lesions disseminated in space and time . CSF oligoclonal bands can now be used to substitute for demonstration of dissemination in time in some settings. Both asymptomatic and now symptomatic MRI lesions can be considered in determining dissemination in space ( optic nerve lesions are still excluded ). Cortical lesions have been added to juxtacortical lesions as determinants for dissemination in space.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Overall disease course is unaffected in pregnancy Pregnant MS patients experience fewer attacks than expected during gestation but more attacks than expected in the first 3 months postpartum. When considering pregnancy as a whole, the overall disease course is unaffected Option: C. MRI has revolutionized the diagnosis This is true because MRI is helpful in finding the characteristic abnormalities which are found in more than 95 percent of patients. More than 90 percent of the lesions visualized by MRI are asymptomatic Option: D. This is an autoimmune disease This is true. Multiple sclerosis is an autoimmune disease of the CNS characterized by chronic inflammation, demyelination, gliosis and neuronal loss.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "There are four patients in the hospital. Patient 1-has sensory loss. Patient 2-has ankylosing spondylitis. Patient 3- has weakness. Patient 4- has paresthesia. Which of the above patients are least likely to develop multiple sclerosis?", "options": [{"label": "A", "text": "1", "correct": false}, {"label": "B", "text": "2", "correct": true}, {"label": "C", "text": "3", "correct": false}, {"label": "D", "text": "4", "correct": false}], "correct_answer": "B. 2", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>2 Ankylosing spondylitis Multiple sclerosis is a demyelinating disorder of the brain and not the spinal cord. Hence, Ankylosing spondylitis is very rare in Multiple Sclerosis. If spinal cord involvement is present it is called Neuromyelitis optica / devic